Idelvion® (coagulation factor IX (Recombinant), albumin fusion protein)
for Hemophilia

Idelvion (coagulation factor IX recombinant, albumin fusion protein) is a long-acting injectable therapy for adults and children with hemophilia B. It is used to manage active bleeding, prevent bleeding during surgery, and reduce bleeding episode frequency. Idelvion temporarily replaces missing factor IX for proper blood clotting. Its genetically fused recombinant factor IX and albumin extend its duration in the body, providing prolonged protection against bleeding.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia